CEREZYME: payments to doctors
Payments that named CEREZYME as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1.8M
- Providers
- 1,986
- Transactions
- 3,426
- Average per transaction
- $524
The per-transaction average — $524 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 1,986 providers the average total is $904, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Sanofi | $1,644,170 | 91.6% |
| Sanofi-aventis U.S. LLC | $123,673 | 6.9% |
| Bioverativ Therapeutics Inc. | $27,736 | 1.5% |